Intra-articular hyaluronic acid for osteoarthritis of the knee

Medicine Today

Volumn 4, Issue 10, 2003, Pages 67-68

  Bagga, Hanish ^a   March, Lyn ^a  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CHONDROITIN; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; FERMATHRON; GLUCOSAMINE; HYALURONIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PLACEBO;

ARTICLE; CLINICAL TRIAL; DATA ANALYSIS; DISEASE CONTROL; DRUG COST; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG TOLERABILITY; EXERCISE; HUMAN; KNEE DISEASE; KNEE OSTEOARTHRITIS; KNEE PAIN; LEG EDEMA; LIFESTYLE; NONHUMAN; OBESITY; PREDICTION; RELIABILITY; SYMPTOMATOLOGY; WEIGHT REDUCTION;

EID: 0344668476     PISSN: 1443430X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. Balazs EA, Watson D, Duff IF, Roseman S. Hyaluronic acid in synovial fluid. I. Molecular parameters of hyaluronic acid in normal and arthritic human fluids. Arthritis Rheum 1967; 10: 357-374.
2. Peyron JG, Balazs EA. Preliminary clinical assessment of Na-hyaluronate injection into human arthritis joints. Pathol Biol (Paris) 1974; 22: 731-736.
3. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum 2000;43: 1905-1915 (www.rheumatology.org/research/guidelines).